Compound ID | 1267
Ivermectin/Colistin
| Spectrum of activity: | Gram-negative |
| Details of activity: | Antibacterial effect of colistin against Col-S and Col-R A. baumannii, P. aeruginosa and K. pneumoniae. |
| Combined with other compounds: | Yes |
| Institute where first reported: | Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, University Hospital Virgen del Rocío, Seville, Spain. Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain., Sevilla, Spain, Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain. Department of Medicine, University of Seville, Seville, Spain., Sevilla, Spain |
| Year first mentioned: | 2019 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| External links: | |
| Guide to Pharmacology: | ivermectin |
| Main Source: | https://www.eccmidlive.org/#!resources/in-vitro-activity-of-ivermectin-in-combination-with-colistin-against-gram-negative-bacilli-5b1695c5-cf06-4761-baee-d2ab3646d5c4 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us.
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.